🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

"I think we've worked hard to make sure that our manufacturing sites in the U.S. are optimized." Teva Pharmaceuticals CEO Richard Francis talks earnings and how the company's supply chain is helping mitigate tariff risks: cnbc.com/video/2025/05/…

Teva Pharmaceutical Industries reported a larger than expected rise in first-quarter profit, helped by strong sales gains for a trio of its branded drugs treating migraines, Huntington's disease and schizophrenia. reut.rs/4m5O1Py reut.rs/4m5O1Py

Today Moody's Ratings has raised Teva’s corporate credit rating to Ba1, outlook stable; from Ba2, outlook positive. Read the PR: ow.ly/84bH50VTzLQ $Teva

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: BiotechTV is at Teva Pharmaceuticals’s Innovation and Strategy Day in New York today. Tune in later for interviews with CEO Richard Francis and Wall Street analysts for their take on the presentation. $TEVA

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: At Teva Pharm US's Innovation & Strategy Day in New York today, CEO Richard Francis discusses what 'Pivot to Growth' means for the company and offers takeaways from the presentation. $TEVA Full video: biotechtv.com/post/teva-inno…

𝐁𝐫𝐢𝐠𝐡𝐭 𝐌𝐢𝐧𝐝𝐬: Piper Sandler Senior Analyst David Amsellam reacts to today's Teva Pharmaceuticals Innovation & Strategy Day and shares his take on the company's pipeline. $TEVA Full video: biotechtv.com/post/piper-san…

Teva Pharmaceutical Industries reported a higher than expected rise in second-quarter profit, helped by strong sales gains of its branded drugs to treat migraines, Huntington's disease and schizophrenia. reut.rs/4l1fNuU reut.rs/4l1fNuU

"When it comes to thinking about tariffs, on our innovative side we have very little exposure." Teva Pharmaceuticals CEO Richard Francis discusses the company's earnings and pharmaceutical pipeline as the industry looks to navigate changes in trade policy: cnbc.com/video/2025/07/…